-
1
-
-
77950261786
-
Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: A retrospective cohort study
-
Nihtyanova SI, Tang EC, Coghlan JG et al. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study. QJM 2010; 103: 109-15.
-
(2010)
QJM
, vol.103
, pp. 109-115
-
-
Nihtyanova, S.I.1
Tang, E.C.2
Coghlan, J.G.3
-
2
-
-
84655175061
-
Understanding fibrosis in systemic sclerosis: Shifting paradigms, emerging opportunities
-
Bhattacharyya S, Wei J, Varga J. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol 2011; 8: 42-54.
-
(2011)
Nat Rev Rheumatol
, vol.8
, pp. 42-54
-
-
Bhattacharyya, S.1
Wei, J.2
Varga, J.3
-
3
-
-
84862765265
-
Unraveling the genetic component of systemic sclerosis
-
Martín JE, Bossini-Castillo L, Martín J. Unraveling the genetic component of systemic sclerosis. Hum Genet 2012; 131: 1023-37.
-
(2012)
Hum Genet
, vol.131
, pp. 1023-1037
-
-
Martín, J.E.1
Bossini-Castillo, L.2
Martín, J.3
-
4
-
-
34548843398
-
A polymorphism in the CTGF promoter region associated with systemic sclerosis
-
Fonseca C, Lindahl GE, Ponticos M et al. A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med 2007; 357: 1210-20.
-
(2007)
N Engl J Med
, vol.357
, pp. 1210-1220
-
-
Fonseca, C.1
Lindahl, G.E.2
Ponticos, M.3
-
5
-
-
84879298794
-
Scleroderma pathogenesis: A pivotal role for fibroblasts as effector cells
-
Gilbane AJ, Denton CP, Holmes AM. Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells. Arthritis Res Ther 2013; 15: 215.
-
(2013)
Arthritis Res Ther
, vol.15
, pp. 215
-
-
Gilbane, A.J.1
Denton, C.P.2
Holmes, A.M.3
-
6
-
-
84897517521
-
Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma
-
Moinzadeh P, Fonseca C, Hellmich M et al. Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma. Arthritis Res Ther 2014; 16: R53.
-
(2014)
Arthritis Res Ther
, vol.16
, pp. R53
-
-
Moinzadeh, P.1
Fonseca, C.2
Hellmich, M.3
-
7
-
-
84922822961
-
Review: Cancer-induced autoimmunity in the rheumatic diseases
-
Shah AA, Casciola-Rosen L, Rosen A. Review: cancer-induced autoimmunity in the rheumatic diseases. Arthritis Rheumatol 2015; 67: 317-26.
-
(2015)
Arthritis Rheumatol
, vol.67
, pp. 317-326
-
-
Shah, A.A.1
Casciola-Rosen, L.2
Rosen, A.3
-
8
-
-
84898775777
-
Prediction of pulmonary complications and long-term survival in systemic sclerosis
-
Nihtyanova SI, Schreiber BE, Ong VH et al. Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol 2014; 66: 1625-35.
-
(2014)
Arthritis Rheumatol
, vol.66
, pp. 1625-1635
-
-
Nihtyanova, S.I.1
Schreiber, B.E.2
Ong, V.H.3
-
9
-
-
84886801549
-
Endothelial injury in a transforming growth factor-dependent mouse model of scleroderma induces pulmonary arterial hypertension
-
Derrett-Smith EC, Dooley A et al. Endothelial injury in a transforming growth factor-dependent mouse model of scleroderma induces pulmonary arterial hypertension. Arthritis Rheum 2013; 65: 2928-39.
-
(2013)
Arthritis Rheum
, vol.65
, pp. 2928-2939
-
-
Derrett-Smith, E.C.1
Dooley, A.2
-
10
-
-
84863812038
-
Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis
-
Maurer B, Reich N, Juengel A e t al. Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis . Ann Rheum Dis 2012; 71: 1382-7.
-
(2012)
Ann Rheum Dis
, vol.71
, pp. 1382-1387
-
-
Maurer, B.1
Reich, N.2
Juengel, A.3
-
11
-
-
84924758403
-
Impaired BMPRII signalling in a TGF dependent mouse model of pulmonary hypertension and in systemic sclerosis
-
Gilbane AJ, Derrett-Smith E, Trinder SL et al. Impaired BMPRII signalling in a TGF dependent mouse model of pulmonary hypertension and in systemic sclerosis. Am J Respir Crit Care Med 2015; 191: 665-77.
-
(2015)
Am J Respir Crit Care Med
, vol.191
, pp. 665-677
-
-
Gilbane, A.J.1
Derrett-Smith, E.2
Trinder, S.L.3
-
12
-
-
84886777196
-
2013 classification criteria for systemic sclerosis: An American College of Rheumatology/European League against Rheumatism collaborative initiative
-
van den Hoogen F, Khanna D, Fransen J et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737-47.
-
(2013)
Arthritis Rheum
, vol.65
, pp. 2737-2747
-
-
Van Den Hoogen, F.1
Khanna, D.2
Fransen, J.3
-
13
-
-
0018887574
-
Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee
-
Preliminary criteria for the classification of systemic sclerosis (scleroderma)
-
Preliminary criteria for the classification of systemic sclerosis (scleroderma) . Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980; 23: 581-90.
-
(1980)
Arthritis Rheum
, vol.23
, pp. 581-590
-
-
-
14
-
-
76649085510
-
Autoantibodies as predictive tools in systemic sclerosis
-
Nihtyanova SI, Denton CP. Autoantibodies as predictive tools in systemic sclerosis. Nat Rev Rheumatol 2010; 6: 112-6.
-
(2010)
Nat Rev Rheumatol
, vol.6
, pp. 112-116
-
-
Nihtyanova, S.I.1
Denton, C.P.2
-
15
-
-
80051468836
-
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): An open-label, randomised phase 2 trial
-
Burt RK, Shah SJ, Dill K et al. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet 2011; 378: 498-506.
-
(2011)
Lancet
, vol.378
, pp. 498-506
-
-
Burt, R.K.1
Shah, S.J.2
Dill, K.3
-
16
-
-
84902844800
-
Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: A randomized clinical trial
-
van Laar JM, Farge D, Sont JK et al.; EBMT/EULAR Scleroderma Study Group. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 2014; 311: 2490-8.
-
(2014)
JAMA
, vol.311
, pp. 2490-2498
-
-
Van Laar, J.M.1
Farge, D.2
Sont, J.K.3
-
17
-
-
34948847074
-
Adult stem cell treatment of scleroderma
-
Tyndall A, Furst DE. Adult stem cell treatment of scleroderma. Curr Opin Rheumatol 2007; 19: 604-10.
-
(2007)
Curr Opin Rheumatol
, vol.19
, pp. 604-610
-
-
Tyndall, A.1
Furst, D.E.2
-
18
-
-
73649119523
-
Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis
-
H errick A L, L unt M, W hidby N e t al. Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis. J Rheumatol 2010; 37: 1162-4.
-
(2010)
J Rheumatol
, vol.37
, pp. 1162-1164
-
-
Errick A L, H.1
Unt M, L.2
Hidby N, W.3
-
19
-
-
84970921186
-
-
Available online at[Accessed 28 October 2015]
-
E uropean Scleroderma Observational Study. Available online at: www.ssc-esos.net [Accessed 28 October 2015].
-
-
-
European Scleroderma Observational Study1
-
20
-
-
66149100618
-
EULAR recommendations for the treatment of systemic sclerosis: A report from the EULAR Scleroderma Trials and Research group (EUSTAR)
-
Kowal-Bielecka O, Landewé R, Avouac J et al; EUSTAR Co-Authors. EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 2009; 68: 620-8.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 620-628
-
-
Kowal-Bielecka, O.1
Landewé, R.2
Avouac, J.3
-
21
-
-
84946741528
-
Consensus best practice pathway of the UK Systemic Sclerosis Study Group: Digital vasculopathy in systemic sclerosis
-
press
-
Hughes M, Ong VH, Anderson ME e t al. Consensus best practice pathway of the UK Systemic Sclerosis Study Group: Digital vasculopathy in systemic sclerosis. Rheumatology 2015, in press.
-
(2015)
Rheumatology
-
-
Hughes, M.1
Ong, V.H.2
Anderson, M.E.3
-
22
-
-
33745227399
-
Cyclophosphamide versus placebo in scleroderma lung disease
-
Tashkin DP, Elashoff R, Clements PJ et al. Scleroderma Lung Study Research Group. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006; 354: 2655-66.
-
(2006)
N Engl J Med
, vol.354
, pp. 2655-2666
-
-
Tashkin, D.P.1
Elashoff, R.2
Clements, P.J.3
-
23
-
-
36249001195
-
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease
-
T ashkin D P, E lashoff R, C lements P J e t al; Scleroderma Lung Study Research Group. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med 2007; 176: 1026-34.
-
(2007)
Am J Respir Crit Care Med
, vol.176
, pp. 1026-1034
-
-
Ashkin D P, T.1
Lashoff R, E.2
Lements P J, C.3
-
24
-
-
33845643063
-
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
-
Hoyles RK, Ellis RW, Wellsbury J et al. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 2006; 54: 3962-70.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 3962-3970
-
-
Hoyles, R.K.1
Ellis, R.W.2
Wellsbury, J.3
-
25
-
-
84890776626
-
Definitions and diagnosis of pulmonary hypertension
-
Hoeper MM, Bogaard HJ, Condliffe R et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol 2013; 62 ( 25 Suppl): D42-50.
-
(2013)
J Am Coll Cardiol
, vol.62
, Issue.25
, pp. D42-50
-
-
Hoeper, M.M.1
Bogaard, H.J.2
Condliffe, R.3
-
26
-
-
84931568718
-
Effects of oral treatments on clinical outcomes in pulmonary arterial hypertension: A systematic review and meta-analysis
-
e14
-
Zhang HD, Zhang R, Jiang X et al. Effects of oral treatments on clinical outcomes in pulmonary arterial hypertension: A systematic review and meta-analysis. Am Heart J 2015; 170: 96-103. e14.
-
(2015)
Am Heart J
, vol.170
, pp. 96-103
-
-
Zhang, H.D.1
Zhang, R.2
Jiang, X.3
-
27
-
-
84890574392
-
Updated treatment algorithm of pulmonary arterial hypertension
-
Galiè N, Corris PA, Frost A et al. Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol 2013; 62 ( 25 Suppl): D60-72.
-
(2013)
J Am Coll Cardiol
, vol.62
, Issue.25
, pp. D60-72
-
-
Galiè, N.1
Corris, P.A.2
Frost, A.3
-
28
-
-
0025152770
-
Outcome of renal crisis in systemic sclerosis: Relation to availability of angiotensin converting enzyme (ACE) inhibitors
-
Steen VD, Costantino Shapiro JP Medsger AP Jr TA. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors. Ann Intern Med 1990; 113: 352-7.
-
(1990)
Ann Intern Med
, vol.113
, pp. 352-357
-
-
Steen, V.D.1
Costantino Shapiro, J.P.2
Medsger, A.P.T.A.3
-
29
-
-
34547822481
-
Scleroderma renal crisis: Patient characteristics and long-term outcomes
-
Penn H, Howie AJ, Kingdon EJ et al. Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM 2007; 100: 485-94.
-
(2007)
QJM
, vol.100
, pp. 485-494
-
-
Penn, H.1
Howie, A.J.2
Kingdon, E.J.3
-
31
-
-
77955729148
-
Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre
-
Thoua NM, Bunce C, Brough G et al. Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre. Rheumatology (Oxford) 2010; 49: 1770-5.
-
(2010)
Rheumatology (Oxford)
, vol.49
, pp. 1770-1775
-
-
Thoua, N.M.1
Bunce, C.2
Brough, G.3
-
32
-
-
85006320635
-
Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms
-
Tauber M, Avouac J, Benahmed A e t al. Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis patients with gastrointestinal symptoms. Clin Exp Rheumatol 2014; 32( 6 Suppl 86): S-82-7.
-
(2014)
Clin Exp Rheumatol
, vol.32
, Issue.6
, pp. S82-S87
-
-
Tauber, M.1
Avouac, J.2
Benahmed, A.3
-
33
-
-
84938958673
-
C onsensus best practice pathway of the UK scleroderma study group: Gastrointestinal manifestations of systemic sclerosis
-
Hansi N, Thoua N, Carulli M e t al. C onsensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis. Clin Exp Rheumatol 2014; 32( 6 Suppl 86): S-214-21.
-
(2014)
Clin Exp Rheumatol
, vol.32
, Issue.6
, pp. S214-S221
-
-
Hansi, N.1
Thoua, N.2
Carulli, M.3
-
34
-
-
84908268041
-
Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses
-
Bretterklieber A, Painsi C, Avian A, Wutte N, Aberer E. Impaired quality of life in patients with systemic sclerosis compared to the general population and chronic dermatoses. BMC Res Notes 2014; 7: 594.
-
(2014)
BMC Res Notes
, vol.7
, pp. 594
-
-
Bretterklieber, A.1
Painsi, C.2
Avian, A.3
Wutte, N.4
Aberer, E.5
-
35
-
-
84902249499
-
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: The DETECT study
-
Coghlan JG, Denton CP, Grünig E et al.; DETECT study group. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 2014; 73: 1340-9.
-
(2014)
Ann Rheum Dis
, vol.73
, pp. 1340-1349
-
-
Coghlan, J.G.1
Denton, C.P.2
Grünig, E.3
-
36
-
-
80052339811
-
Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations
-
Meune C, Avouac J, Airò P et al. Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations. Arthritis Rheum 2011; 63: 2790-6.
-
(2011)
Arthritis Rheum
, vol.63
, pp. 2790-2796
-
-
Meune, C.1
Avouac, J.2
Airò, P.3
-
37
-
-
84901599531
-
Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis
-
Domsic RT, Nihtyanova SI, Wisniewski SR et al. Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis. Arthritis Rheumatol 2014; 66: 1616-24.
-
(2014)
Arthritis Rheumatol
, vol.66
, pp. 1616-1624
-
-
Domsic, R.T.1
Nihtyanova, S.I.2
Wisniewski, S.R.3
|